ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
10/23/2024
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Case type
Recorded events
Latest update
Classification
Trademark type
Nice classes
Filing date
Registration date
Expiration date
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Structured fields from the responsible authority and the official record.
Status date
Last transaction
Responsible office
Status code
Official register
Filing basis
First use anywhere
First use in commerce
Drawing code
Owner type
Owner location
Examiner
Law office
Current location
Holders
Representatives
David S. Kerr BERG HILL GREENLEAF RUSCITTI LLP
Nice Classes
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Research and development of pharmaceuticals, therapeutics, and biologics, namely, vaccines, antibiotics, vaccines generated in a cell-free protein synthesizing system, antibiotics generated in a cell-free protein synthesizing system, proteins generated in a cell-free protein synthesizing system, and enzymes generated in a cell-free protein synthesizing system; research and development in the field of bioinformatics and production of proteins in cell-free systems for the development of vaccines, and antibiotics; medical research and development in the field of synthetic biology, molecular biology, genetic engineering and bioinformatics; research and development of new drug compounds for therapeutic use; research and development of new biological products for therapeutic use; research and development of antibiotic compounds for therapeutic use; research and development of methods of high-throughput screening of biological materials; research and development of methods of rapid-prototyping of biological materials; research and development of methods of real-time metabolic profiling of bacteria, fungi and plants to discover, characterize and produce bioactive products; design and development of nucleic acids, proteins, enzymes, antibiotic compounds, and drug compounds for use in pharmaceuticals, biotechnology, and medical and diagnostic applications using predictive bioinformatics; bioinformatics scientific research services, namely, identifying new drug compounds from analysis of genomic data
History of USPTO decisions and trademark events.
16 publications found
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
10/23/2024
REGISTERED-PRINCIPAL REGISTER
12/28/2021
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
11/20/2021
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
11/19/2021
STATEMENT OF USE PROCESSING COMPLETE
11/19/2021
CASE ASSIGNED TO INTENT TO USE PARALEGAL
11/19/2021
USE AMENDMENT FILED
10/29/2021
TEAS STATEMENT OF USE RECEIVED
10/29/2021
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
05/04/2021
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/09/2021
PUBLISHED FOR OPPOSITION
03/09/2021
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/17/2021
APPROVED FOR PUB - PRINCIPAL REGISTER
02/03/2021
ASSIGNED TO EXAMINER
01/31/2021
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/26/2020
NEW APPLICATION ENTERED
09/21/2020
Continuous trademark protection
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.